Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Pasithea Therapeutics Corp. (KTTA) had Return on Tangible Equity of -53.71% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.72M |
|
-- |
|
-- |
|
$3.81M |
|
$-3.81M |
|
$0.09M |
|
$-3.72M |
|
$-3.72M |
|
$-3.72M |
|
$-3.72M |
|
$-3.72M |
|
$-3.72M |
|
$-3.81M |
|
$-3.65M |
|
5.64M |
|
5.64M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$8.64M |
|
$0.11M |
|
$8.37M |
|
$17.01M |
|
$1.74M |
|
-- |
|
$0.09M |
|
$1.83M |
|
$15.18M |
|
$6.92M |
|
$15.18M |
|
7.44M |
|
| Cash Flow Statement Financials | |
$-6.92M |
|
-- |
|
$7.21M |
|
$6.92M |
|
$7.22M |
|
$0.29M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.48% |
|
|
Return on Tangible Equity |
-53.71% |
-21.85% |
|
-24.48% |
|
$2.04 |
|
$-1.23 |
|
$-1.23 |
|